Personensuche
Personensuche
Es wurde 1 Person gefunden.
Anschrift
Tüschener Weg 40
45239 Essen
45239 Essen
Funktionen
-
---, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patientsIn: European Journal of Cancer (EJC), Jg. 147, 2021, S. 142 – 150
-
Joint Statement of the German Respiratory Society and German Society of Thoracic Surgery in Cooperation with the German Radiological Society : Structural Prerequisites of Centres for Interventional Treatment of EmphysemaIn: Respiration: International Journal of Thoracic Medicine, Jg. 100, 2021, Nr. 1, S. 52 – 58
-
Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft für Thoraxchirurgie in Kooperation mit der Deutschen Röntgengesellschaft : Strukturvoraussetzungen von Zentren für die interventionelle EmphysemtherapieIn: Pneumologie, Jg. 74, 2020, Nr. 1, S. 17 – 23
-
Prognostic markers in resected large cell neuroendocrine carcinoma : A multicentre retrospective analysisIn: Journal of Thoracic Disease, Jg. 12, 2020, Nr. 3, S. 466 – 476DOI (Open Access)
-
A prospective comparison of growth patterns with radiomorphology in 232 lung metastases—basis for patient tailored resection planning?In: Journal of Thoracic Disease, Jg. 11, 2019, Nr. 7, S. 2822 – 2831DOI (Open Access)
-
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoidsIn: European Journal of Cardio-Thoracic Surgery, Jg. 55, 2019, Nr. 2, S. 273 – 279DOI (Open Access)
-
Aortobronchial fistula caused by an endobronchial lobar Y stent : a word of cautionIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 27, 2018, Nr. 4, S. 632 – 633DOI (Open Access)
-
Independent predictors for higher postoperative pain intensity during recovery after open thoracic surgery : A retrospective analysis in 621 patientsIn: Pain Medicine, Jg. 19, 2018, Nr. 8, S. 1667 – 1673
-
Same-day Routine Chest-X Ray After Thoracic Surgery is Not Necessary!In: Zentralblatt für Chirurgie, Jg. 143, 2018, Nr. 1, S. 96 – 101
-
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma : Results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective DatabaseIn: European Journal of Cardio-Thoracic Surgery, Jg. 52, 2017, Nr. 2, S. 339 – 345
-
Erroneous diagnosis of small cell lung cancer based on small biopsies with far-reaching consequences: Case report of a typical carcinoid tumorIn: Journal of Thoracic Disease, Jg. 9, 2017, Nr. 2, S. E99 – E102DOI (Open Access)
-
Growth patterns of pulmonary metastases : Should we adjust resection techniques to primary histology and size?In: European Journal of Cardio-Thoracic Surgery, Jg. 52, 2017, Nr. 1, S. 39 – 46
-
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung CancerIn: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. 1, S. 54 – 64DOI (Open Access)
-
Pulmonary metastasectomy for sarcoma-Essen experienceIn: Journal of Thoracic Disease, Jg. 9, 2017, S. S1278 – S1281DOI (Open Access)
-
Sarcomatoid carcinoma of the lung: A rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stagesIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 24, 2017, Nr. 3, S. 407 – 413
-
The role of surgery in high grade neuroendocrine tumours of the lungIn: Journal of Thoracic Disease, Jg. 9, 2017, Nr. Suppl. 15, S. S1474 – S1483DOI (Open Access)
-
A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine CarcinomasIn: The Annals of Thoracic Surgery, Jg. 101, 2016, Nr. 5, S. 1909 – 1914
-
Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 PatientsIn: Respiration: International Journal of Thoracic Medicine, Jg. 92, 2016, Nr. 6, S. 414 – 419DOI (Open Access)
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology, Jg. 142, 2016, Nr. 4, S. 795 – 805
-
Short- and Mid-Term Changes in Lung Function after Bilateral Pulmonary MetastasectomyIn: The Thoracic and Cardiovascular Surgeon, Jg. 64, 2016, Nr. 2, S. 139 – 145
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 21, S. 2526 – 2533
-
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyIn: Journal of Thoracic Disease, Jg. 7, 2015, Nr. 3, S. 264 – 272
-
Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma : a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working GroupIn: European Journal of Cardio-Thoracic Surgery, Jg. 48, 2015, Nr. 1, S. 55 – 64
-
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasIn: Lung Cancer, Jg. 88, 2015, Nr. 1, S. 34 – 41
-
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 35, S. 4194 – 4201
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsIn: BMC Cancer, Jg. 15, 2015, Nr. 1, S. 363DOI (Open Access)
-
Prognostic model of survival for typical bronchial carcinoid tumours : analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working GroupIn: European Journal of Cardio-Thoracic Surgery, Jg. 48, 2015, Nr. 3, S. 441 – 447
-
Pulmonary manifestation of a condition resembling Kasabach–Merritt syndrome in a woman with abdominal angiomatosis associated with consumptive coagulopathy – surgical management : a case reportIn: Journal of Medical Case Reports, Jg. 9, 2015, S. 107DOI (Open Access)
-
Tracheaverletzungen, Insuffizienz von Bronchusstumpf/-anastomose und Rekurrensparese : Management der Komplikationen in der ThoraxchirurgieIn: Der Chirurg, Jg. 86, 2015, Nr. 5, S. 410 – 418
-
Extended resections for lung cancer with invasion of the chest wall, superior sulcus and spineIn: Der Onkologe, Jg. 20, 2014, Nr. 10, S. 969 – 981
-
Management of a Chest-Wall Soft-Tissue Tumor Caused by an Infection with the Larval Tapeworm Pathogen Taenia crassicepsIn: American Journal of Tropical Medicine and Hygiene, Jg. 91, 2014, Nr. 3, S. 541 – 543DOI, Online Volltext (Open Access)
-
Modified Clagett Procedure Is Effective for Methicillin-Resistant Staphylococcus aureus Postpneumonectomy Empyema : A Case ReportIn: World Journal of Oncology, Jg. 5, 2014, Nr. 4, S. 178 – 180DOI (Open Access)
-
Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. 7510
-
Repair of tracheobronchial injuriesIn: Thoracic Surgery Clinics, Jg. 24, 2014, Nr. 1, S. 41 – 50
-
Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal CarcinoidIn: Journal of Thoracic Oncology, Jg. 9, 2014, Nr. 1, S. 132 – 134
-
Surgery of Primary Lung Cancer with Oligometastatic M1b Synchronous Single Brain Metastasis : Analysis of 37 CasesIn: The Thoracic and Cardiovascular Surgeon, Jg. 62, 2014, Nr. 7, S. 612 – 615
-
Thymoma and thymic carcinoma : a multivariate analysis of prognostic factors in 220 patientsIn: Journal of Thoracic Oncology, Jg. 9, 2014, Nr. 10, Suppl. 4, S. S241 – S242
-
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)In: Lung Cancer, Jg. 82, 2013, Nr. 1, S. 83 – 89
-
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionationIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 9, S. 2107 – 2115
-
Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer stagingIn: Annals of Oncology, Jg. 24, 2013, Nr. 11, S. 2866 – 2870
-
Determination of lung segments in computed tomography images using the Euclidean distance to the pulmonary arteryIn: Medical Physics, Jg. 40, 2013, Nr. 9, S. 091912
-
ERCC1, MLH1, MSH2, MSH6, and βiII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesotheliomaIn: Clinical Lung Cancer, Jg. 14, 2013, Nr. 5, S. 558 – 567
-
Epidural analgesia is not superior to systemic postoperative analgesia with regard to preventing chronic or neuropathic pain after thoracotomyIn: Journal of Cardiothoracic Surgery, Jg. 8, 2013, Nr. 1, S. 127
-
Evaluation of a Novel Endobronchial Ultrasound-Guided Lymph Node Forceps in Enlarged Mediastinal Lymph NodesIn: Respiration: International Journal of Thoracic Medicine, Jg. 86, 2013, Nr. 3, S. 229 – 236
-
Glanduläres Papillom des rechten Hauptbronchus : Nachweis einer Exon-2-Mutation des KRAS-Gens (c.35G>A)In: Der Pathologe, Jg. 34, 2013, Nr. 4, S. 338 – 342
-
Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomyIn: The Annals of Thoracic Surgery, Jg. 95, 2013, Nr. 3, S. 1006 – 1011
-
Verletzungen des TracheobronchialbaumsIn: Zentralblatt für Chirurgie, Jg. 138, 2013, Nr. 1, S. 111 – 116
-
Changes in Lung Function Parameters After Wedge Resections : A Prospective Evaluation of Patients Undergoing MetastasectomyIn: Chest, Jg. 141, 2012, Nr. 6, S. 1482 – 1489
-
Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalitiesIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 140
-
Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/ToxizitätenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 34
-
Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural MesotheliomaIn: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, S. 1440 – 1448DOI (Open Access)
-
Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histologyIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 15, 2012, Nr. 4, S. 612 – 617
-
Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 96 – 96
-
Lung segment geometry study : simulation of largest possible tumours that fit into bronchopulmonary segmentsIn: The Thoracic and Cardiovascular Surgeon, Jg. 60, 2012, Nr. 2, S. 93 – 100
-
Risk factors for impaired lung function after pulmonary metastasectomy : a prospective observational study of 117 casesIn: European Journal of Cardio-Thoracic Surgery, Jg. 42, 2012, Nr. 2, S. e22 – e27
-
Staging des Lungenkarzinoms : Welche Rolle spielt die Mediastinoskopie heute?In: Zentralblatt für Chirurgie, Jg. 137, 2012, Nr. 3, S. 242 – 247
-
Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerIn: British Journal of Cancer (BJC), Jg. 107, 2012, Nr. 5, S. 823 – 830DOI (Open Access)
-
10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 494
-
A new technique for complete intraluminal repair of iatrogenic posterior tracheal lacerationsIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 12, 2011, Nr. 1, S. 6 – 9
-
Growth patterns of lung metastases from sarcomasIn: Virchows Archiv, Jg. 459, 2011, Nr. 2, S. 213 – 219
-
Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7047
-
Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 187, 2011, Nr. Suppl. 1, S. 68 – 69
-
Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen LungenkarzinomsIn: Der Onkologe, Jg. 17, 2011, Nr. 8, S. 691 – 701
-
Safety distance in the resection of colorectal lung metastases : A prospective evaluation of satellite tumor cells with immunohistochemistryIn: The Journal of Thoracic and Cardiovascular Surgery, Jg. 141, 2011, Nr. 5, S. 1218 – 1222DOI (Open Access)
-
A new endoscopic technique for intraluminal repair of posterior tracheal lacerationIn: The Annals of Thoracic Surgery, Jg. 90, 2010, Nr. 2, S. 686 – 688
-
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancerIn: The Thoracic and Cardiovascular Surgeon, Jg. 139, 2010, Nr. 6, S. 1424 – 1430DOI (Open Access)
-
Pulmonary metastases of breast cancer : When is resection indicated?In: European Journal of Cardio-Thoracic Surgery, Jg. 34, 2008, Nr. 6, S. 1228 – 1234DOI (Open Access)
-
Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 36 – 37 -
Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 23 -
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 226 – 227 -
Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 90, 2014, Nr. 1, Supplement, S. S146 – S147 -
Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 5 – 6 -
Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl 1, S. 17 -
Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 17 -
Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 19 -
Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 87 -
Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 84, 2012, Nr. 3, Supplement, S. S154 -
Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 72, 2012, Nr. 8, Suppl., S. 1713
-
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S376 – S377 -
Lung volume reduction surgeryIn: Chest surgery / Dienemann, Hendrik; Hoffmann, Hans; Detterbeck, Frank C. (Hrsg.). Heidelberg [u.a.]: Springer, 2015, S. 255 – 262
-
Bedeutung lokaler Ausbreitungsmuster von Lungenmetastasen für die Indikationsstellung, Prognose und technische Durchführung der LungenmetastasektomieDuisburg, Essen, 2013